Exclusive special offer and discount title banner vector image

NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

North America Neurovascular Devices / Interventional Neurology Market by Product (Embolization Devices, Accessory Devices, Revascularization Devices, Thrombectomy Devices, Embolic Protection Devices) Market by Application (Aneurysm, Ischemic Stroke, Stenosis, Arteriovenous Malformation, Other Applications) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The North America neurovascular devices/interventional neurology market is estimated to rise with a CAGR of 5.39% over the forecasting years of 2023 to 2032, capturing a revenue share of $2225.69 million by 2032.

The market growth of the region is fuelled by key factors such as the increase in neurovascular illnesses, the rising investments in cutting-edge medical technologies, as well as the growing access to interventional neurology treatments. However, the North America neurovascular devices/interventional neurology market will likely be hindered due to financial restrictions, in addition to lengthy and difficult regulatory approval procedures.

North_America_Neurovascular_Devices_Interventional_Neurology_Market

To Know More About This Report, Request a Free Sample Copy

The North America neurovascular devices/interventional neurology market growth study includes an in-depth assessment of the United States and Canada. The prevalence of neurovascular illnesses, such as intracranial aneurysms, ischemic strokes, arteriovenous malformations (AVMs), as well as other cerebrovascular diseases, has been on the rise in the United States. Moreover, with the country’s aging population, the risk of these conditions is increasing, leading to a greater demand for neurovascular devices for diagnosis and treatment. The Brain Aneurysm Foundation highlights that approximately 30,000 Americans experience a brain aneurysm rupture annually. In order to address these emerging health challenges, ongoing advancements in neuro-interventional technologies have expanded the range of available treatments. Accordingly, minimally invasive procedures, such as stent-assisted coiling, endovascular coiling, and flow diversion, are gaining popularity among patients as well as healthcare professionals owing to their increased effectiveness and preference. 

Furthermore, access to expert neurovascular care has also improved significantly across the United States with the establishment of primary stroke centers and comprehensive stroke centers. These facilities require modern neurovascular devices to provide high-quality care to patients. As per the Journal of the American College of Emergency Physicians Open, out of 5,533 US EDs, 44% (2,446) are designated as stroke centers, encompassing Comprehensive Stroke Centers, Primary Stroke Centers, Acute Stroke Ready Hospitals, and Thrombectomy-capable Stroke Centers. As the landscape of neurovascular care continues to evolve, the demand for advanced neurovascular devices is poised to increase, catering to the growing healthcare needs of the aging United States population. In turn, these factors are expected to contribute to the North America neurovascular devices/interventional neurology market growth during the forecast period. 

The North America neurovascular devices/interventional neurology market is segmented into product and application. The product segment includes embolization device, accessory device, revascularization device, thrombectomy device, and embolic protection device.

Embolization is a highly effective medical technique used to block blood vessels and prevent blood flow to specific areas of the body. It finds extensive application in treating brain aneurysms, where neurovascular devices play a crucial role in blocking the aneurysm. The neurovascular devices employed in embolization procedures include aneurysm clips, coil-assist stents, and embolic coils.

Some of the major players operating in the North America neurovascular devices/interventional neurology market include Stryker Corporation, Medtronic Inc, etc.

Stryker Corporation, headquartered in the United States, is a medical technology company that provides a diverse array of innovative products as well as services across orthopedics, neurotechnology and spine, and medical and surgical products. Moreover, some of the key products of the company include neurosurgical, orthopedic implants, surgical equipment, endoscopic and communications systems, surgical navigation systems, emergency medical equipment, intensive care disposable products, neurovascular and spinal devices, and medical devices utilized in a variety of spheres.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product and Application
Countries AnalyzedThe United States and Canada
Companies AnalyzedAcandis GmbH, Asahi Intecc, B Braun Melsungen AG, Balt, Integer Holdings Corporation, Johnson & Johnson (Cerenovus), Kaneka Corporation, Medtronic Inc, Memry Corporation, MicroPort Scientific Corporation, Penumbra Inc, Phenox Inc, Rapid Medical, Stryker Corporation, Terumo Corporation, Sensome

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
    5. MAJOR MARKET FINDINGS
      1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
      2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
      3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS 
      2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
      3. GERIATRIC POPULATION’S VULNERABILITY TO NEUROVASCULAR DISEASES
      4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
    2. KEY RESTRAINTS
      1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
      2. LACK OF TRAINED NEUROSURGEONS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
    4. MARKET CONCENTRATION ANALYSIS
    5. VALUE CHAIN ANALYSIS
  5. MARKET BY PRODUCT
    1. EMBOLIZATION DEVICES
      1. EMBOLIC COILS
        1. COATED DETACHABLE COILS
        2. BARE DETACHABLE COILS
      2. COIL ASSIST STENT
      3. CLIPPINGS
      4. COIL ASSIST BALLOON
    2. ACCESSORY DEVICES
      1. MICROCATHETERS
      2. MICRO GUIDEWIRES
    3. REVASCULARIZATION DEVICES
      1. CAROTID ARTERY STENTS
      2. FLOW DIVERSION STENTS
    4. THROMBECTOMY DEVICES
      1. CLOT RETRIEVAL DEVICES
      2. SUCTION AND ASPIRATION DEVICES
      3. SNARES
    5. EMBOLIC PROTECTION DEVICES
      1. BALLOON OCCLUSION DEVICES
      2. DISTAL FILTER DEVICES
  6. MARKET BY APPLICATION
    1. ANEURYSM
    2. ISCHEMIC STROKE
    3. STENOSIS
    4. ARTERIOVENOUS MALFORMATION (AVM)
    5. OTHER APPLICATIONS
  7. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
      3. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
      4. NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  8. COMPETITIVE LANDSCAPE
    1. ACANDIS GMBH
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
    2. ASAHI INTECC
      1. COMPANY OVERVIEW
      2. PRODUCT LIST 
    3. BALT
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
    4. B BRAUN MELSUNGEN AG
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    5. INTEGER HOLDINGS CORPORATION
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    6. JOHNSON & JOHNSON (CERENOVUS)
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    7. KANEKA CORPORATION
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
    8. MEDTRONIC INC
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    9. MEMRY CORPORATION
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
    10. MICROPORT SCIENTIFIC CORPORATION
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    11. PENUMBRA INC
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
    12. PHENOX INC
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    13. RAPID MEDICAL
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    14. SENSOME
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    15. STRYKER CORPORATION
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES
    16. TERUMO CORPORATION
      1. COMPANY OVERVIEW
      2. PRODUCT LIST
      3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY

TABLE 2: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: NORTH AMERICA EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: NORTH AMERICA EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 14: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 16: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 18: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 20: NORTH AMERICANEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK

TABLE 21: KEY PLAYERS OPERATING IN NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET

TABLE 22: LIST OF MERGERS & ACQUISITIONS

TABLE 23: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 24: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 25: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: MARKET CONCENTRATION ANALYSIS

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022

FIGURE 7: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 8: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIZATION DEVICES, IN 2022

FIGURE 9: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC COILS, 2023-2032 (IN $ MILLION)

FIGURE 10: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC COILS, IN 2022

FIGURE 11: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COATED DETACHABLE COILS, 2023-2032 (IN $ MILLION)

FIGURE 12: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BARE DETACHABLE COILS, 2023-2032 (IN $ MILLION)

FIGURE 13: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST STENT, 2023-2032 (IN $ MILLION)

FIGURE 14: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLIPPINGS, 2023-2032 (IN $ MILLION)

FIGURE 15: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST BALLOON, 2023-2032 (IN $ MILLION)

FIGURE 16: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 17: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY ACCESSORY DEVICES, IN 2022

FIGURE 18: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICROCATHETERS, 2023-2032 (IN $ MILLION)

FIGURE 19: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICRO GUIDEWIRES, 2023-2032 (IN $ MILLION)

FIGURE 20: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 21: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY REVASCULARIZATION DEVICES, IN 2022

FIGURE 22: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CAROTID ARTERY STENTS, 2023-2032 (IN $ MILLION)

FIGURE 23: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY FLOW DIVERSION STENTS, 2023-2032 (IN $ MILLION)

FIGURE 24: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 25: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY THROMBECTOMY DEVICES, IN 2022

FIGURE 26: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLOT RETRIEVAL DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 27: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SUCTION AND ASPIRATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 28: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SNARES, 2023-2032 (IN $ MILLION)

FIGURE 29: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 30: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC PROTECTION DEVICES, IN 2022

FIGURE 31: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BALLOON OCCLUSION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 32: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISTAL FILTER DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 33: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 34: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ANEURYSM, 2023-2032 (IN $ MILLION)

FIGURE 35: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ISCHEMIC STROKE, 2023-2032 (IN $ MILLION)

FIGURE 36: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY STENOSIS, 2023-2032 (IN $ MILLION)

FIGURE 37: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2023-2032 (IN $ MILLION)

FIGURE 38: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 39: NORTH AMERICA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 40: UNITED STATES NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: CANADA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

Request Customization
Request Customization
Request free sample